Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer

by Endo, T., Funayama, Y., Furukawa, K., Hizawa, N., Ichimura, H., Inagaki, M., Kaburagi, T., Kikuchi, N., Kikuchi, S., Koyama, N., Kurishima, K., Miyazaki, K., Nakamura, H., Numata, T., Saito, K., Sato, Y., Satoh, H., Sekine, I., Shiozawa, T., Tamura, T., Yamada, H., Yamamoto, Y.
Published 2022